Carcinogenicity of Tricycloquinazoline and Its Derivatives
Author Information
Author(s): R. W. Baldwin, G. J. Cunningham, M. W. Partridge, H. J. Vipond
Primary Institution: University of Nottingham
Hypothesis
The study aims to determine the essential molecular criteria for the carcinogenicity of Tricycloquinazoline (TCQ) and its derivatives.
Conclusion
The study found that 2-methyl-TCQ is virtually inactive as a carcinogen, while other monomethyl derivatives exhibit varying levels of carcinogenic activity.
Supporting Evidence
- 2-methyl-TCQ showed low carcinogenic activity with only 9% of treated mice developing tumors.
- 1-, 3-, and 4-methyl-TCQ derivatives were found to be carcinogenic but less so than TCQ.
- 3-fluoro-TCQ and 3-bromo-TCQ showed high carcinogenic activity with 76% and 68% tumor incidences, respectively.
Takeaway
This study looked at how different versions of a chemical called TCQ affect the growth of tumors in mice, finding that some versions are much less harmful than others.
Methodology
Mice were treated with various TCQ derivatives through skin painting and monitored for tumor development over a period of up to 12 months.
Limitations
The study primarily focused on a limited number of derivatives and their effects on a specific strain of mice.
Participant Demographics
Stock albino mice (Schofield Strain) of both sexes, aged 6 to 8 weeks.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website